beta-alanine has been researched along with fibrinogen in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bowie, EJ; Daniels, TM; Gastineau, DA; Gertz, MA; Kyle, RA | 1 |
Furlan, M | 1 |
Bennick, A; Brosstad, F; Haddeland, U; Sletten, K | 1 |
Barrett, J; Bartis, J; Bozarth, J; Edwards, S; Ellars, C; Harris, TD; Kalogeropoulos, S; Lazewatsky, J; Liu, S; Nguyen, T; Onthank, D; Robinson, S; Silva, P; Yalamanchili, P | 1 |
Baghaei, F; Blixter, IF; Gustafsson, KM; Hillarp, A; Lindahl, TL; Sten-Linder, M; Stigendal, L; Strandberg, K | 1 |
Cheng, A; Hoylaerts, MF; Peetermans, WE; Schneewind, O; VAN Ryn, J; Vanassche, T; Verhaegen, J; Verhamme, P | 1 |
Fountzilas, C; George, J; Levine, R | 1 |
Bailleul, E; Chatelain, B; Coucke, W; Demulder, A; Devreese, K; Douxfils, J; Jochmans, K; Mullier, F; Soumali, MR; Van Blerk, M; Van de Walle, P; Vernelen, K; Wijns, W | 1 |
8 other study(ies) available for beta-alanine and fibrinogen
Article | Year |
---|---|
Inhibitor of the thrombin time in systemic amyloidosis: a common coagulation abnormality.
Topics: Amyloidosis; beta-Alanine; Blood Coagulation Disorders; Fibrinogen; Heart Failure; Humans; Nephrotic Syndrome; Thrombin; Thrombin Time | 1991 |
Purification of fibrinogen.
Topics: beta-Alanine; Blood Platelets; Chemical Precipitation; Chromatography, Affinity; Chromatography, Gel; Chromatography, Ion Exchange; Ether; Fibrin; Fibrinogen; Glycine; Humans; Polyethylene Glycols | 1984 |
Freeze-dried fibrinogen or fibrinogen in EDTA stimulate the tissue-type plasminogen activator-catalysed conversion of plasminogen to plasmin.
Topics: Amino Acid Sequence; beta-Alanine; Chemical Precipitation; Edetic Acid; Fibrinogen; Fibrinolysin; Freeze Drying; Humans; Molecular Sequence Data; Plasminogen; Protein Conformation; Solubility; Thrombin; Tissue Plasminogen Activator | 1994 |
Design, synthesis, and evaluation of radiolabeled integrin alpha v beta 3 receptor antagonists for tumor imaging and radiotherapy.
Topics: Adenocarcinoma; Animals; beta-Alanine; Binding, Competitive; Cell-Matrix Junctions; Dose-Response Relationship, Radiation; Drug Design; Female; Fibrinogen; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Integrin alpha5beta1; Integrin alphaVbeta3; Integrins; Jurkat Cells; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Neoplasms; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Radioisotopes; Radionuclide Imaging; Receptors, Vitronectin; Sulfonamides; Tissue Distribution; Vitronectin; Yttrium Radioisotopes | 2003 |
Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays.
Topics: Activated Protein C Resistance; Administration, Oral; Adult; Aged; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation; Blood Coagulation Tests; Dabigatran; Dose-Response Relationship, Drug; Female; Fibrinogen; Humans; Male; Middle Aged; Partial Thromboplastin Time; Prothrombin Time; Reproducibility of Results; Thrombin | 2011 |
Inhibition of staphylothrombin by dabigatran reduces Staphylococcus aureus virulence.
Topics: Animals; Bacterial Adhesion; Benzimidazoles; beta-Alanine; Dabigatran; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Immunohistochemistry; Mice; Placebos; Staphylococcus aureus; Thrombin; Virulence | 2011 |
Dabigatran overdose secondary to acute kidney injury and amiodarone use.
Topics: Acute Kidney Injury; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Creatinine; Dabigatran; Drug Overdose; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Thrombin Time | 2013 |
Influence of dabigatran and rivaroxaban on routine coagulation assays. A nationwide Belgian survey.
Topics: Administration, Oral; Anticoagulants; Antithrombins; Belgium; Benzimidazoles; beta-Alanine; Biomarkers; Blood Coagulation; Dabigatran; Dose-Response Relationship, Drug; Equipment Design; Fibrinogen; Health Care Surveys; Humans; Laboratory Proficiency Testing; Morpholines; Observer Variation; Partial Thromboplastin Time; Predictive Value of Tests; Prothrombin Time; Quality Indicators, Health Care; Reproducibility of Results; Rivaroxaban; Thiophenes; Time Factors | 2015 |